Study measures copper levels in breast milk for Wilson’s disease
Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study measures how much copper is present in breast milk in people with Wilson’s disease. It aims to provide safer guidance for breastfeeding during treatment, including during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years old or older
- You have Wilson’s disease that meets the study’s scoring rules (Leipzig score)
- You are pregnant (at any stage) or currently planning/able to breastfeed during the study period
- You can give your written consent freely to join the study
- You are covered by a social security system (or are an affiliate/beneficiary)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether Wilson disease affects the heart, using MRI scans (and possibly contrast dye). Your results may help doctors better understand cardiac (heart) involvement and how it progresses in Wilson disease.
This study looks at how Wilson's disease might affect hormone levels in children. It aims to understand if the disease or its treatment can cause endocrine problems.
This study follows people who have the genetic cause of Wilson disease, including people who feel well and family members. Researchers want to better understand Wilson disease and what to watch for over time.
This early-stage trial tests LY-M003, a new gene therapy treatment for Wilson's disease—a rare genetic condition where copper builds up in the body. The study aims to see if this injection is safe and whether it can help patients who are already on standard copper-lowering medicines.
This trial tests an experimental mRNA treatment (DSL101) for adults with Wilson disease. It's for people whose condition is stable on current therapy and who have certain genetic markers. The goal is to see if the new treatment can help the body process copper better and reduce the need for standard medicines.
This trial is a patient registry that collects health information from people with Wilson’s disease, including those without symptoms yet and those taking any type of treatment. It helps researchers understand the disease and how it progresses, which can support future studies and care improvements.
Hear when a new Wilson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.